RADIANCE 2: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 25: | Line 25: | ||
|- | |- | ||
|} | |} | ||
<span style="font-size:85%">The previous information was derived from ClinicalTrials.gov on 08/18/2014 using the identification number | <span style="font-size:85%">The previous information was derived from ClinicalTrials.gov on 08/18/2014 using the identification number NCT00134238.</span> | ||
==Study Description== | ==Study Description== | ||
| Line 61: | Line 61: | ||
|} | |} | ||
<span style="font-size:85%">The previous information was derived from ClinicalTrials.gov on 09/19/2013 using the identification number | <span style="font-size:85%">The previous information was derived from ClinicalTrials.gov on 09/19/2013 using the identification number NCT00134238.</span> | ||
==Eligibility Criteria== | ==Eligibility Criteria== | ||
Revision as of 16:01, 18 August 2014
|
High Density Lipoprotein Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Clinical Trials |
|
Case Studies |
|
RADIANCE 2 On the Web |
|
American Roentgen Ray Society Images of RADIANCE 2 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Official Title
Objective
Sponsor
Timeline
| Timeline | |
| Start Date | |
| End Date | |
| Status | |
The previous information was derived from ClinicalTrials.gov on 08/18/2014 using the identification number NCT00134238.
Study Description
| Study Description | |
| Study Type | |
| Study Phase | |
| Study Design | |
| Allocation | |
| Endpoint | |
| Interventional Model | |
| Masking | |
| Study Details | |
| Primary Purpose | |
| Condition | |
| Intervention | |
| Study Arms | |
| Population Size | |
The previous information was derived from ClinicalTrials.gov on 09/19/2013 using the identification number NCT00134238.
Eligibility Criteria
Inclusion Criteria
Exclusion Criteria
Outcomes
Primary Outcomes
Publications
Results
Conclusion
Pending